M7E-79990-47940
3 vaccinations
4 coded responses
20 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 021 / MA
- Registered
- 2022-06-29
- Relationship
- Child or adolescent in my care
- Guardian
- EM9-23208-74211
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Dose 1 — Moderna
-
2022-06-29
Registered in v-safe
- 2022-06-29
- 2022-07-01
- 2022-07-08
-
2022-07-15
Survey response — day 21, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-07-22
-
2022-07-23
Dose 2 — Moderna
- 2022-07-29
- 2022-07-31
- 2022-08-06
- 2022-08-13
- 2022-08-20
- 2022-08-27
- 2022-09-03
-
2022-10-22
Survey response — 3 months, dose 2, under 3MedDRA: Gastrointestinal viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: (b)(6) currently has a GI virus she picked up at daycareMedDRA releases: 2024-11 · check-in free text available
-
2023-01-21
Survey response — 6 months, dose 2, under 3MedDRA: Fatigue, Gastrointestinal viral infection, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-03-05
Dose 3 — Moderna
-
2023-03-22
Survey response — day 14, dose 3, under 3MedDRA: Pneumonia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-03-22
Report sent to call center — day 14, dose 3, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-03-23
- 2023-03-26
- 2023-04-02
- 2023-04-09
- 2023-04-18
- 2023-06-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Moderna | No |
| 2 | 2022-07-23 | Moderna | No |
| 3 | 2023-03-05 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Runny nose
Release 12 (Under 3) — 3 months, dose 2, under 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal viral infection | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release